Menu
02b-653x337_toraymixin_eaa

Sepsis and septic shock

TORAYMYXIN®

State-of-the-art therapy for patients with endotoxic septic shock

Septic shock is associated with an unacceptable high mortality and a significant economic burden to the sanitary system. Endotoxin is the most potent trigger of the septic cascade and during the progress of sepsis, endotoxin levels can increase up to 1000 fold, even when cultures result negative for Gram-negative bacteria.

Toraymyxin®  Polymyxin B hemoperfusion therapy – from Toray Medical Ltd. (Japan), is the state-of-the-art therapy for endotoxin removal in septic shock patients. More than 150,000 patients have been treated with this innovative therapy and more than 250 peer-reviewed articles have been published, demonstrating the beneficial effects on hemodynamics, organ function and mortality.

EAA™Endotoxin Activity Assay – is the only FDA approved diagnostic assay to detect endotoxin activity in human whole blood. The EAA™ diagnostic test is performed in less than 30 minutes. EAA™ is the diagnostic assay to identify patients with endotoxic septic shock.

chronic-kidney-disease-653x337

Chronic kidney disease

Filtryzer® PMMA

A personalized therapy based on the individual needs of each patient

acute-respiratory-failure-653x337

Acute respiratory failure

ProLUNG®

A minimally invasive extracorporeal CO2 removal system for ventilatory support

Focus on

Vicenza-Course-2019-653x337px

VICENZA COURSE 2019

The 37th VICENZA COURSE on AKI and CRRT organized by Professor Claudio Ronco is held in Vicenza 28–30 May 2019

SMART-2019-653x337px

SMART 2019 – MILAN

We are present at the 30th SMART Meeting, 8-10 May 2019 in Milan, the annual meeting in anesthesia and resuscitation in intensive care.

Come and meet us at our booth #30-31.

WKD-2019-653x337px

WORLD KIDNEY DAY – MARCH 14, 2019

World Kidney Day is a global initiative aimed at raising awareness of the importance of our kidneys. The campaign sets out to raise awareness of the high and increasing burden of kidney disease worldwide and of the need for strategies for kidney disease prevention and management.